What is ITRM's current stock price?

ITRM (Iterum Therapeutics plc) is currently trading at $0.03 with a market cap of $1.6M.

What sector is Iterum Therapeutics plc in?

Iterum Therapeutics plc (ITRM) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ITRM Iterum Therapeutics plc

Healthcare

$0.03-10.98%ClosedMarket Cap: $1.6M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-0.34

P/S

7.52

EV/EBITDA

-1.11

DCF Value

$-1.10

FCF Yield

-679.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

-171.3%

Operating Margin

-5202.8%

Net Margin

-6913.1%

ROE

602.4%

ROA

-82.9%

ROIC

-77.0%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 null	$390.0K	$-9.0M	$—
Q2 null	$0.00	$-6.5M	$—
Q1 null	$0.00	$-4.9M	$—
Q4 null	$0.00	$-6.6M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Neutral

2026-03-30

Trading Activity

Insider Trades

View All

Dunne Michael W.director

BuyThu Nov 20

Dunne Michael W.director

BuyTue Aug 12

Coyne Christineofficer: Chief Commercial Officer

SellThu Jul 03

Coyne Christine

SellThu Jul 03

Whalen Joseph John

SellTue Mar 18

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

3.01

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.

Peers